Patents/Assignees

THERAVANCE BIOPHARMA R&D IP, LLC

37 patents in portfolio

US12398135utility2025
Dimethyl Amino Azetidine Amides as JAK Inhibitors
0 cites
US12384761utility2025
Imidazolo Indazole Compounds as JAK Inhibitors
0 cites
US12358931utility2025
3-((1r,3s,5s)-3-((7-((5-methyl-1h-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) Propanenitrile as a JAK Kinase Inhibitor
0 cites
US12351561utility2025
Crystalline (2s,4r)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic Acid and Uses Thereof
0 cites
US12258316utility2025
Biphenyl Compounds Useful as Muscarinic Receptor Antagonists
0 cites
US12239638utility2025
Crystalline Form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compound
0 cites
US12172994utility2024
Pyrimidine Compound as JAK Kinase Inhibitor
0 cites
US12122773utility2024
Crystalline Hydrate of a JAK Inhibitor Compound
0 cites
US12016835utility2024
Neprilysin Inhibitors
0 cites
US11919888utility2024
Neprilysin Inhibitors
0 cites
US11878977utility2024
JAK Inhibitors Containing a 4-membered Heterocyclic Amide
0 cites
US11858898utility2024
Crystalline Freebase Forms of a Biphenyl Compound
0 cites
US11851443utility2023
Neprilysin Inhibitors
0 cites
US11845747utility2023
Ester and Carbonate Pyrimidine Compounds as JAK Kinase Inhibitors
0 cites
US11814377utility2023
Pyrimidine Compound as JAK Kinase Inhibitor
0 cites
US11795180utility2023
Formulation of a Pan-jak Inhibitor
0 cites
US11786517utility2023
Methods of Treatment Using a JAK Inhibitor Compound
0 cites
US11780852utility2023
Methods for Treating Crohn's Disease Using 3-((1r,3s,5s)-3-((7-((5-methyl-1h-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile
0 cites
US11730720utility2023
ALK5 Inhibitors
0 cites
US11723900utility2023
4-[2-(2-fluorophenoxymethyl)phenyl]piperidine Compounds
0 cites

Page 1 of 2Next →